Cytek Biosciences, Inc.
CTKB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001831915
No open-market purchases or sales by Cytek Biosciences, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $361.0M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Cytek Biosciences, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 136 | 153 | +17 |
| Shares | 75.0M | 77.3M | +2.29M (+3.1%) |
| Value | $415.3M | $501.4M | +$86.1M (+20.7%) |
New holders (33)
Institutions that held Cytek Biosciences, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (16)
Institutions that held Cytek Biosciences, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| FIL Ltd | 573,600 | $3.18M |
| Jacobs Levy Equity Management, Inc | 182,713 | $1.01M |
| Voloridge Investment Management, LLC | 131,578 | $728.9K |
| First Trust Advisors LP | 76,810 | $425.5K |
| Jump Financial, LLC | 73,697 | $408.3K |
| EntryPoint Capital, LLC | 51,030 | $282.7K |
| Public Employees Retirement System of Ohio | 48,520 | $268.8K |
| Gsa Capital Partners LLP | 37,884 | $210.0K |
| Oxford Asset Management LLP | 25,257 | $139.9K |
| Deerfield Management Company, L.P. (Series C) | 17,586 | $97.4K |
| Everence Capital Management Inc | 16,760 | $93.0K |
| Simplex Trading, LLC | 1,440 | $7.00K |
| Allspring Global Investments Holdings, LLC | 929 | $5.15K |
| Quest Partners LLC | 68 | $377 |
| Mendota Financial Group, LLC | 13 | $73 |
| Capital Performance Advisors LLP | 12 | $66 |